Alaa Afify

1.9k total citations
57 papers, 1.5k citations indexed

About

Alaa Afify is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Alaa Afify has authored 57 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 14 papers in Cell Biology and 13 papers in Oncology. Recurrent topics in Alaa Afify's work include Proteoglycans and glycosaminoglycans research (13 papers), Glycosylation and Glycoproteins Research (7 papers) and Cancer Genomics and Diagnostics (6 papers). Alaa Afify is often cited by papers focused on Proteoglycans and glycosaminoglycans research (13 papers), Glycosylation and Glycoproteins Research (7 papers) and Cancer Genomics and Diagnostics (6 papers). Alaa Afify collaborates with scholars based in United States, Egypt and Netherlands. Alaa Afify's co-authors include Sridevi Devaraj, Basim Al‐Khafaji, Hon Fong L. Mark, Ishwarlal Jialal, Augusto F. G. Paulino, Bruce A. Werness, Andrew A. Bremer, Phillip R. Purnell, Laura A. Nguyen and Rosa M. Dávila and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Cancer.

In The Last Decade

Alaa Afify

56 papers receiving 1.4k citations

Peers

Countries citing papers authored by Alaa Afify

Since Specialization

Citations

This map shows the geographic impact of Alaa Afify's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alaa Afify with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alaa Afify more than expected).

Fields of papers citing papers by Alaa Afify

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alaa Afify. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alaa Afify. The network helps show where Alaa Afify may publish in the future.

Co-authorship network of co-authors of Alaa Afify

This figure shows the co-authorship network connecting the top 25 collaborators of Alaa Afify. A scholar is included among the top collaborators of Alaa Afify based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alaa Afify. Alaa Afify is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ethnicity, consanguinity, and genetic architecture of hypertrophic cardiomyopathy 2023 ·European Heart Journal ·Mona Allouba, Roddy Walsh, Alaa Afify, (unknown), (unknown), (unknown), (unknown), Pantazis Theotokis, (unknown), (unknown), Rachel Buchan, Risha Govind, Nicola Whiffin, (unknown), Ahmed ElGuindy, James S. Ware, Paul J.R. Barton, Magdi H. Yacoub, Yasmine Aguib	21
2	Raman-based cytopathology: an approach to improve diagnostic accuracy in medullary thyroid carcinoma 2020 ·Biomedical Optics Express ·(unknown), Michael J. Campbell, Alaa Afify, Eric C. Huang, James W. Chan	6
3	Immune Checkpoint Inhibitor-Induced Myasthenia Gravis in a Patient with Advanced NSCLC and Remote History of Thymoma 2019 ·Clinical Lung Cancer ·(unknown), Alaa Afify, (unknown), (unknown), David P. Richman, Jonathan W. Riess	10
4	Hyperspectral Raman microscopy can accurately differentiate single cells of different human thyroid nodules 2019 ·Biomedical Optics Express ·(unknown), Michael J. Campbell, Alaa Afify, Eric C. Huang, James W. Chan	21
5	The expression of CD44v6 in colon: from normal to malignant 2015 ·Annals of Diagnostic Pathology ·Alaa Afify, Blythe Durbin‐Johnson, (unknown), (unknown)	15
6	Living with uncertainty: Equivocal Pap test results and the evolution of ASC terminology 2009 ·Diagnostic Cytopathology ·Lydia Pleotis Howell, (unknown), John W. Bishop, Alaa Afify	5
7	The Diagnostic Utility of Cell Blocks Prepared From Residual SurePath Pap Material for Detection of Human Papilloma Virus 2009 ·Applied immunohistochemistry & molecular morphology ·Alaa Afify, Cindy Yu, (unknown), Lydia Pleotis Howell	9
8	Role of CD44s and CD44v6 on human breast cancer cell adhesion, migration, and invasion 2009 ·Experimental and Molecular Pathology ·Alaa Afify, Phillip R. Purnell, Laura A. Nguyen	90
9	Correlation of cytologic examination with ELISA assays for hyaluronan and soluble CD44v6 levels in evaluation of effusions 2007 ·Diagnostic Cytopathology ·Alaa Afify, (unknown), Lydia Pleotis Howell	10
10	Temporal Variation in the Distribution of Hyaluronic Acid, CD44s, and CD44v6 in the Human Endometrium Across the Menstrual Cycle 2006 ·Applied immunohistochemistry & molecular morphology ·Alaa Afify, (unknown), Augusto F. G. Paulino	44
11	Diagnostic Utility of GLUT-1 Expression in the Cytologic Evaluation of Serous Fluids 2005 ·Acta Cytologica ·Alaa Afify, (unknown), Lydia Pleotis Howell, Augusto F. G. Paulino	18
12	Adequacy evaluation of fine-needle aspiration biopsy in the breast health clinic setting 2004 ·Cancer ·Lydia Pleotis Howell, Regina Gandour‐Edwards, (unknown), Robin L. Davis, Shagufta Yasmeen, Alaa Afify	11
13	Her2/neu is preferentially expressed in squamous cell carcinoma of the tonsil compared to other squamous cell carcinomas of the head and neck 2002 ·Laboratory Investigation ·Augusto F. G. Paulino, Alaa Afify	1
14	Diagnostic Use of Muscle Markers in the Cytologic Evaluation of Serous Fluids 2002 ·Applied immunohistochemistry & molecular morphology ·Alaa Afify, Basim Al‐Khafaji, Augusto F. G. Paulino, Rosa M. Dávila	24
15	Comparison of ThinPrep and TriPath PREP liquid‐based preparations in nongynecologic specimens: A pilot study 2001 ·Diagnostic Cytopathology ·Claire W. Michael, (unknown), (unknown), Alaa Afify, Basim Al‐Khafaji	41
16	Cytologic artifacts and pitfalls of thyroid fine-needle aspiration using ThinPrep® 2001 ·Cancer ·Alaa Afify, Jing Liu, Basim Al‐Khafaji	74
17	Fluorescent in situ Hybridization Detection of HER-2/neu Gene Amplification in Rhabdomyosarcoma 1998 ·Pathobiology ·Hon Fong L. Mark, Stephen Brown, (unknown), (unknown), Alaa Afify	26
18	Stage I and Stage II Infiltrating Ductal Carcinoma of the Breast Analyzed for Chromosome 8 Copy Number Using Fluorescent in situ Hybridization 1997 ·Pathobiology ·Hon Fong L. Mark, William Taylor, Alaa Afify, (unknown), Mary Rausch, (unknown), (unknown), (unknown), Kirby I. Bland	21
19	A subset of gestational trophoblastic disease characterized by abnormal chromosome 8 copy number detected by fluorescence in situ hybridization 1997 ·Cancer Genetics and Cytogenetics ·H.F.L. Mark, Alaa Afify, William Taylor, (unknown), (unknown)	5
20	Fluorescentin situ hybridization assessment of chromosome 8 copy number in breast cancer 1996 ·Breast Cancer Research and Treatment ·Alaa Afify, Kirby I. Bland, Hon Fong L. Mark	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact